Anti-inflammatory properties of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin).
D000402:Airway Obstruction / Q000139:chemically induced / Q000188:drug therapy; D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000139:chemically induced / Q000188:drug therapy / Q000276:immunology; D001241:Aspirin / Q000627:therapeutic use; D001920:Bradykinin; D002351:Carrageenan; D004285:Dogs; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004655:Emulsions; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000188:drug therapy; D005620:Freund's Adjuvant; D007191:Indazoles; D008297:Male; D008970:Molecular Weight; D009161:Mycobacterium; D010080:Oxazoles / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000139:chemically induced / Q000188:drug therapy; D011422:Propionates / Q000627:therapeutic use; D051381:Rats; D013424:Sulfanilamides; D013585:Synovitis / Q000139:chemically induced / Q000188:drug therapy; D013997:Time Factors; D014527:Uric Acid; D015003:Yeasts
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D004655:Emulsions; D007191:Indazoles; D010080:Oxazoles; D011422:Propionates; D013424:Sulfanilamides; D014527:Uric Acid; D002351:Carrageenan; D005620:Freund's Adjuvant; D001241:Aspirin; D001920:Bradykinin